Comparison of three instruments for measuring red blood cell aggregation.

Department of Physiology, Faculty of Medicine, Akdeniz University, Antalya, Turkey.
Clinical hemorheology and microcirculation (Impact Factor: 3.4). 01/2009; 43(4):283-98. DOI: 10.3233/CH-2009-1240
Source: PubMed

ABSTRACT The International Society for Clinical Hemorheology organized a workshop to compare three instruments for measuring RBC aggregation: LORCA, Myrenne Aggregometer and RheoScan-A. The Myrenne Aggregometer provides indices at stasis (M) and at low shear (M1), with four indices obtained with the LORCA and RheoScan-A: amplitude (AMP), half-time (T1/2), surface area (SA) above (LORCA) or below (RheoScan-A) the syllectogram, and the ratio (AI) of the area above (LORCA) or below (RheoScan-A) the syllectogram to total area (AI). Intra-assay reproducibility and biological variability were determined; also studied were RBC in diluted plasma and in 1% 500 kDa dextran, and 0.003% glutaradehyde (GA)-treated cells in plasma. All measurements were performed at 37 degrees C. Standardized difference values were used as a measure of power to detect differences. Salient results were: (1) intra-assay variations below 5% except for RheoScan-A AMP and SA; (2) biological variability greatest for T1/2 with other indices similar for the three devices; (3) all instruments detected progressive changes with plasma dilution; (4) the Myrenne and LORCA, but not the RheoScan-A, detected differences for cells in dextran; (5) GA-treatment significantly affected the LORCA (AMP, T1/2, SA, AI), the RheoScan-A (AMP, SA, AI) and the Myrenne M parameter. It is concluded that: (a) the LORCA, Myrenne and the RheoScan-A have acceptable precision and suitable power for detecting reduced aggregation due to plasma dilution; (b) greatly enhanced RBC aggregation may not be sensed by the RheoScan-A while the Myrenne M1 index may be insensitive to minor increases of cell rigidity; (c) future studies should define each instrument's useful range for detecting RBC aggregation.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A new method is described in this paper that allows measurement of red blood cell (RBC) aggregation indexes in disposable glass tubes within minutes. Light transmission through the RBC suspension filled into a microhematocrit capillary at stasis is recorded during RBC aggregation; a novel method assures an initial dispersion of aggregates in the capillary. The resulting light transmittance-time data are analyzed to calculate various parameters. Measurement of erythrocyte sedimentation rate (ESR) and RBC aggregation using well established methods and the newly developed capillary tube aggregometer in blood samples with a wide range of RBC aggregation indicated significant correlations between these parameters. Additionally, light transmittance during complete disaggregation allows estimating hematocrit, thereby enabling hematocrit correction of the measured and calculated parameters. The newly developed capillary tube RBC aggregometer is suitable for use as a method to rapidly monitor disease activity and the acute phase response, especially at the point-of-care (e.g., health care facilities, physician's office) and for field studies.
    Clinical hemorheology and microcirculation 01/2011; 47(4):295-305. · 3.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Red blood cells (RBC) in normal human blood undergo reversible aggregation at low flow or stasis. The extent and kinetics of this phenomenon have been studied using various optical and electrical methods, yet results using such methods are not always in concordance. This study employed a horizontal glass tube in which blood flow could be established, then abruptly stopped. Normal blood and RBC suspensions with enhanced or decreased aggregation were studied. Light transmittance (LT) and electrical impedance at 100 kHz were recorded during high-shear flow and for 120 s after flow was abruptly stopped during which RBC aggregation occurs. Capacitance values were also obtained based on the imaginary part of impedance data and recorded. Various aggregation parameters were calculated, using the time course of LT, impedance, and capacitance, then compared with each other and with results from laboratory aggregometers. RBC aggregation parameters were calculated, using the time course of impedance data often failed to correlate with known changes of aggregation, even reporting aggregation for cells in nonaggregating media (i.e., RBC in buffered saline). Alternatively, RBC aggregation parameters based upon the time course of capacitance data are in general agreement with those derived from LT data and with RBC aggregation indexes, measured using commercial instruments.
    IEEE transactions on bio-medical engineering 11/2009; 57(4):969-78. · 2.15 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The reversible aggregation of red blood cells (RBC) is of current basic science and clinical interest. Using a flow channel and light transmittance (LT) through RBC suspensions, we have examined the effects of wavelength (500 to 900 nm) on the static and dynamic aspects of RBC aggregation for normal blood and suspensions with reduced or enhanced aggregation; the effects of oxygenation were also explored. Salient observations include: 1. significant effects of wavelength on aggregation parameters reflecting the extent of aggregation (i.e., number of RBC per aggregate); 2. no significant effects of wavelength on parameters reflecting the time course of RBC aggregation; 3. a prominent influence of hemoglobin oxygen saturation on both extent and time-course related aggregation parameters measured at wavelengths less than 700 nm, but only on the time-course at 800 nm; and 4. the power of parameters in detecting a given alteration of RBC aggregation is affected by wavelength, in general being greater at higher wavelengths. It is recommended that light sources with wavelengths around 800 nm be used in instruments for measuring RBC aggregation via LT.
    Journal of Biomedical Optics 11/2011; 16(11):117006. · 2.88 Impact Factor

Full-text (2 Sources)

Available from
Jun 4, 2014